An Updated Review Of Different Types Of Nanoparticle Based Drug Delivery Systems

Abstract

Traditional drug delivery systems have a number of drawbacks, including limited targeting, low therapeutic indices, poor water solubility, and drug resistance induction. Nanoparticle delivery systems are devised and employed as drug carriers to address the disadvantages of traditional drug delivery pathways. Nanoparticle-based drug delivery systems (NDDSs), also known as nanomedicines, have seen accelerated growth in recent decades due to their unique features when compared to traditional drug formulations. However, due to a variety of obstacles, only a few nanomedicines are now on the market or in clinical trials. The most extensively investigated forms of drug delivery systems are dendrimers, liposomes, inorganic and composite with some of them being used in clinical therapy.